ACADIA Pharmaceuticals
ACAD
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California.
Insider trades and stock quote 2024-2026
All insider trades at ACADIA Pharmaceuticals
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
8/6/2026
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$29.2 |
$417,604 |
|
8/5/2026
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$29.0 |
$169,638 |
|
7/30/2026
|
Sell |
Thompson, Elizabeth H.z. |
EVP, Head of Research & Dev |
$26.2 |
$432,663 |
|
6/26/2026
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$26.1 |
$297,912 |
|
5/26/2026
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$21.2 |
$114,393 |
|
5/4/2026
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$21.8 |
$29,024 |
|
5/4/2026
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$21.8 |
$76,396 |
|
4/7/2026
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$22.2 |
$22,866 |
|
4/7/2026
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$22.2 |
$60,140 |
|
3/26/2026
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$21.7 |
$24,011 |
|
3/26/2026
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$21.7 |
$69,456 |
|
3/25/2026
|
Sell |
Rhodes, Jennifer J. |
EVP, CHIEF LEGAL OFFICER, SEC |
$21.5 |
$82,531 |
|
3/25/2026
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$21.5 |
$17,885 |
|
3/25/2026
|
Sell |
Owen, Catherine E. |
Chief Executive Officer |
$21.5 |
$249,932 |
|
3/25/2026
|
Sell |
Thompson, Elizabeth H.z. |
EVP, Head of Research & Dev |
$21.5 |
$73,749 |
|
3/25/2026
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$21.5 |
$89,680 |
|
2/9/2026
|
Sell |
Rhodes, Jennifer J. |
EVP, CHIEF LEGAL OFFICER, SEC |
$23.4 |
$162,491 |
|
11/18/2025
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$23.7 |
$96,754 |
|
11/18/2025
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$23.7 |
$243,114 |
|
11/10/2025
|
Sell |
Daly, James M. |
Director |
$22.4 |
$670,983 |
|
9/15/2025
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$23.6 |
$82,728 |
|
9/2/2025
|
Sell |
Garofalo, Elizabeth A. |
Director |
$26.0 |
$41,560 |
|
8/18/2025
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$25.2 |
$554,024 |
|
6/4/2025
|
Sell |
Brege, Laura |
Director |
$21.8 |
$314,634 |
|
5/16/2025
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$25.0 |
$50,000 |
|
5/16/2025
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$22.5 |
$90,000 |
|
5/2/2025
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$14.6 |
$51,071 |
|
5/2/2025
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$14.6 |
$19,374 |
|
4/8/2025
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$14.8 |
$15,235 |
|
4/8/2025
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$14.8 |
$40,133 |
|
3/26/2025
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$17.0 |
$54,066 |
|
3/26/2025
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$17.0 |
$18,670 |
|
3/5/2025
|
Sell |
Garofalo, Elizabeth A. |
Director |
$18.2 |
$89,673 |
|
2/24/2025
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$20.0 |
$15,429 |
|
2/24/2025
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$20.0 |
$9,481 |
|
11/19/2024
|
Sell |
Schneyer, Mark C. |
EVP, CHIEF FINANCIAL OFFICER |
$16.8 |
$172,454 |
|
11/19/2024
|
Sell |
Kihara, James |
PRINCIPAL ACCOUNTING OFFICER |
$16.8 |
$68,467 |
|
11/19/2024
|
Sell |
Teehan, Brendan |
EVP, COO, HEAD OF COMMERCIAL |
$16.8 |
$173,630 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Free Updates via Email
Please confirm your email address